This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2023-2024.
Company Filing History:
Years Active: 2023-2024
Title: The Innovations of Jennifer Koenitzer
Introduction
Jennifer Koenitzer is a notable inventor based in Ingelheim am Rhein, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of methods for high-yield protein production. With a total of 2 patents, her work has had a substantial impact on the industry.
Latest Patents
One of her latest patents focuses on the identification of genomic integration sites for heterologous polynucleotides in Chinese Hamster Ovary (CHO) cells. This invention aims to enhance RNA and protein production by integrating heterologous polynucleotides into the S100A gene cluster of the CHO genome. The methods developed allow for the reliable and stable production of proteins of interest at high yields, making it a valuable advancement in biopharmaceutical manufacturing.
Career Highlights
Jennifer Koenitzer is currently employed at Boehringer Ingelheim International GmbH, where she continues to innovate in the field of biotechnology. Her expertise and dedication have positioned her as a key player in her organization, contributing to advancements that benefit the industry.
Collaborations
Throughout her career, Jennifer has collaborated with esteemed colleagues such as Jochen Schaub and Christian Bernloehr. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Jennifer Koenitzer's contributions to biotechnology through her patents and work at Boehringer Ingelheim International GmbH exemplify her commitment to innovation. Her advancements in protein production are paving the way for future developments in the field.
